Share price of this healthcare stock fell by nearly 7.64% to Rs. 185.4 in the trading session of March 1st, compared to its previous closing price of Rs. 200.75, after a foreign investor sold its stake in the company.
With a market capitalisation of Rs. 1,571.35 crores, the share price of GPT Healthcare Limited moved down by 5.16 percent and closed at Rs. 190.35.
The fluctuations in the share price were observed after Nomura Singapore Limited sold 4,53,693 equity shares in GPT Healthcare at an average target price of Rs. 202.46, totalling nearly Rs. 9.18 crore.
Nomura Singapore Limited, based in the Dubai International Financial Centre, provides financial services and is engaged in offering asset management, research analysis, portfolio construction, financial planning, and advisory services to institutional and private clients.
GPT Healthcare came up with its IPO issue of Rs. 525.14 crore on 22nd February 2024 and got listed on the exchange on 29th February 2024.
In terms of financials, the company’s revenue from operations reduced by nearly 18.6 percent YoY from Rs. 172 crore in Q2 FY22-23 to Rs. 204 crore in Q2 FY23-24, accompanied by an increase in the net profit of 35.3 percent YoY, from Rs. 17 crore in Q2 FY22-23 to Rs. 23 crore in Q2 FY23-24.
The healthcare arm of GPT Group, GPT Healthcare Limited, owns and operates multispeciality local tertiary care hospitals in Eastern India under the ILS Hospitals brand.
ILS Hospitals is a multispecialty neighbourhood tertiary care hospital, established by the GPT Group in the year 2000.
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
